A carregar...
Atorvastatin and Fenofibrate have Comparable Effects on VLDL-Apolipoprotein C-III Kinetics in Men with the Metabolic Syndrome
OBJECTIVES: The metabolic syndrome (MetS) is characterised by insulin resistance and dyslipidemia that may accelerate atherosclerosis. Disturbed apolipoprotein (apo) C-III metabolism may account for dyslipidemia in these subjects. Atorvastatin and fenofibrate decrease plasma apoC-III, but the underl...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2734980/ https://ncbi.nlm.nih.gov/pubmed/18566295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.108.170530 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|